MPM Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

MPM Asset Management’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,843,388	Closed	-$27.2M	–	9
2020 Q3	$27.2M	Sell	1,843,388 -325,303	-15%	-$4.96M	5.07%	7
2020 Q2	$32.1M	Hold	2,168,691	–	–	9.56%	5
2020 Q1	$23.8M	Hold	2,168,691	–	–	14.47%	4
2019 Q4	$19M	Hold	2,168,691	–	–	8.38%	5
2019 Q3	$16.2M	Hold	2,168,691	–	–	6.93%	5
2019 Q2	$20.2M	Hold	2,168,691	–	–	8.16%	5
2019 Q1	$11.4M	Hold	2,168,691	–	–	4.7%	5
2018 Q4	$9.65M	Hold	2,168,691	–	–	8.17%	3
2018 Q3	$17.5M	Hold	2,168,691	–	–	11.87%	3
2018 Q2	$15.2M	Hold	2,168,691	–	–	5.9%	3
2018 Q1	$30.9M	Hold	2,168,691	–	–	11.89%	3
2017 Q4	$19M	Hold	2,168,691	–	–	7.61%	3
2017 Q3	$25.4M	Hold	2,168,691	–	–	12.38%	2
2017 Q2	$30.3M	Hold	2,168,691	–	–	13.16%	2
2017 Q1	$29.8M	Hold	2,168,691	–	–	14.31%	2
2016 Q4	$15.6M	Hold	2,168,691	–	–	7.34%	3
2016 Q3	$32.9M	Hold	2,168,691	–	–	10.77%	2
2016 Q2	$21.4M	Hold	2,168,691	–	–	6.93%	2
2016 Q1	$28.9M	Buy	+2,168,691	New	+$27.3M	8.95%	3

Other funds holding SNDX

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MPM Asset Management's SNDX Position: Q4 2020 in Review

MPM Asset Management sold out of Syndax Pharmaceuticals (SNDX) in Q4 2020, closing a stake of 1,843,388 shares — an estimated $27.2M sold.

MPM Asset Management first reported a position in SNDX in Q1 2016 and held it in 19 quarters. The position peaked at $32.9M in Q3 2016. 142 funds tracked by Wall St. Rank hold SNDX as of Q4 2020.

MPM Asset Management reported no remaining Syndax Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
MPM Asset Management sold 1,843,388 Syndax Pharmaceuticals shares in Q4 2020, an estimated $27.2M.
MPM Asset Management first reported a position in Syndax Pharmaceuticals in Q1 2016 and held it in 19 quarters.
MPM Asset Management's Syndax Pharmaceuticals position peaked at $32.9M in Q3 2016.
142 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2020.

Based on MPM Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.